CDH1 and neoplasm: However an inherent problem with this evaluation is weighing the meaning of discrepancies with the pathological diagnosis, as a morphological diagnosis may not be able to discern underlying molecular differences when the tumor types may share very similar lineages, even if markers like CDH1 are also employed in diagnosis.